Antidepressant drug switching in the Swiss population with a focus on Escitalopram and drugs with pharmacogenetic dosing guidelines: a drug utilization study using claims data.
- DOI
- 10.1038/s41397-025-00382-1
- Published
- 2025 Aug 8
- Container
- The pharmacogenomics journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41397-025-00382-1,
title = {Antidepressant drug switching in the Swiss population with a focus on Escitalopram and drugs with pharmacogenetic dosing guidelines: a drug utilization study using claims data.},
author = {Roth MM and Meier CR and Huber CA and Meyer Zu Schwabedissen HE and Allemann S and Schneider C},
year = {2025},
journal = {The pharmacogenomics journal},
doi = {10.1038/s41397-025-00382-1},
url = {https://doi.org/10.1038/s41397-025-00382-1}
}RIS
TY - JOUR TI - Antidepressant drug switching in the Swiss population with a focus on Escitalopram and drugs with pharmacogenetic dosing guidelines: a drug utilization study using claims data. AU - Roth MM AU - Meier CR AU - Huber CA AU - Meyer Zu Schwabedissen HE AU - Allemann S AU - Schneider C PY - 2025 JO - The pharmacogenomics journal DO - 10.1038/s41397-025-00382-1 UR - https://doi.org/10.1038/s41397-025-00382-1 ER -
APA
MM, R., CR, M., CA, H., HE, M. Z. S., S, A., & C, S. (2025). Antidepressant drug switching in the Swiss population with a focus on Escitalopram and drugs with pharmacogenetic dosing guidelines: a drug utilization study using claims data.. The pharmacogenomics journal. https://doi.org/10.1038/s41397-025-00382-1
Source records
- pubmed · retrieved 2026-09-26T15:18:35.922Z